Oppenheimer Holdings Inc. reports developments tied to its wealth management, securities brokerage, investment banking, and capital markets businesses conducted through Oppenheimer & Co. Inc. and related entities. Recurring updates include quarterly earnings, advisory and underwriting activity, sales and trading conditions, private client division changes, and asset management-related measures within the Wealth Management segment.
Company news also covers additions to investment banking and public finance capabilities, including equity capital markets, debt private placements, municipal underwriting and trading, and sector-focused advisory coverage. Governance, capital actions, and legal or compensation items that affect reported results may also appear in company disclosures.
Oppenheimer has appointed Rabi Karki as Head of Asset Management & Wealth Management for EMEA. Based in London, Karki brings over 20 years of experience, including roles at Barclays and J.P. Morgan. He will collaborate with U.S. counterparts to enhance Oppenheimer's financial advisory services. CEO Max Lami highlighted Karki's industry insights and potential to provide value to clients. This appointment is expected to strengthen Oppenheimer's presence in the asset management sector across Europe and beyond.
Oppenheimer & Co. Inc. will host its fifth annual Blockchain and Digital Assets Summit on November 17, 2022, a virtual event showcasing key participants in the blockchain sector. Notable companies attending include Blockchain.com, Coinbase, and Fidelity Digital Assets. Analysts Timothy Horan and Owen Lau emphasize the transformative potential of blockchain in creating new internet access and decentralized finance opportunities. The Summit will feature discussions on trends in DeFi, NFTs, payments, capital markets, and regulatory aspects, aimed at facilitating industry dialogue.
Oppenheimer & Co. Inc. announced the successful recruitment of the Meridian Wealth Group, expanding its Nashville office, which opened in March 2022. Led by industry veteran John Wade, the addition aims to enhance services for high-net-worth clients in a rapidly growing market. The Meridian team emphasizes customized solutions and client-focused service. Oppenheimer is committed to providing these new partners with tools and resources for long-term growth, reflecting its dedication to expanding its footprint in economically vibrant areas.
Oppenheimer Holdings reported third-quarter 2022 net income of $4.5 million ($0.40 per share), a significant decline from $26.3 million ($2.07 per share) in Q3 2021. Revenue fell by 6.7% to $294.1 million, driven by challenging market conditions and an adverse arbitration decision. Key earnings segments showed mixed results: Private Client revenue increased 11% to $178.6 million, while Capital Markets dropped 29.3% to $90.9 million. Despite these challenges, the firm maintained a robust balance sheet, with strong regulatory capital and increased book value per share to $70.23.
Oppenheimer & Co. Inc. has expanded its Global Fund Placement and Advisory Group with the addition of Charles Buisseret as Managing Director and Makayla Stephens as Director. Both will work in the U.S. alongside a cohesive team previously united at another firm. This strategic move aims to enhance services for alternative investment firms, particularly in primary funds and GP stakes. With this expansion, Oppenheimer continues to strengthen its private markets capabilities, crucial for its core sectors like Technology and Healthcare.
Summary not available.
Oppenheimer & Co. Inc. has appointed Joel Sendek as Managing Director and Head of Healthcare Life Sciences Equity Research, bolstering its research team amid evolving industry opportunities. Sendek, with extensive experience as a biotech analyst and CFO at several companies, joins to provide enhanced insights for investors in biotechnology and pharmaceuticals. His leadership aims to meet growing investor demand for informed analysis in this critical sector, as emphasized by executives John Parks and Michael Margolis during the announcement.
Oppenheimer & Co. Inc. has appointed Brad Watkins as Chief Financial Officer, effective August 1, 2022. With extensive experience in the financial services sector, notably at KPMG, Watkins will oversee Oppenheimer's financial operations and long-term budget planning. He joins at a pivotal time for the firm, which aims to enhance its operating model and drive growth. Chairman and CEO Albert G. Lowenthal emphasizes Watkins' expertise will be crucial as the company navigates an evolving market landscape.
Oppenheimer Holdings has authorized a new share repurchase program allowing the buyback of up to 536,500 shares of its Class A non-voting common stock, which is approximately 4.8% of its total outstanding shares. This program supplements the previous authorization still in effect, bringing the total to 540,778 shares available for repurchase. The purchases will be conducted in the open market at prevailing prices using available cash, contributing positively to shareholder value as all acquired shares will be canceled.
Oppenheimer Holdings Inc. reported a net loss of $3.9 million or $(0.32) EPS for Q2 2022, down from a profit of $31.2 million or $2.46 EPS in Q2 2021. Revenue decreased 30.3% to $237.2 million from $340.3 million year-over-year, primarily due to a significant downturn in equity capital market activity. Wealth Management performed relatively well, but overall metrics were affected by high inflation and rising interest rates. The firm repurchased 885,230 shares during the quarter, maintaining strong capital levels despite the loss.